Results 91 to 100 of about 96,180 (101)

The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic Initiative

International Journal of Molecular Sciences, 2016
Nelia Hernández, Maria Isabel Lucena Gonzalez   +1 more
exaly  

Minimizing DILI risk in drug discovery — A screening tool for drug candidates

Toxicology in Vitro, 2015
Simone Schadt, Stefan Kustermann, Stephen Fowler   +2 more
exaly  

In vitro to in vivo extrapolation and species response comparisons for drug-induced liver injury (DILI) using DILIsym™: a mechanistic, mathematical model of DILI

Journal of Pharmacokinetics and Pharmacodynamics, 2012
Alison Harrill, Paul Watkins, Melvin E Andersen   +2 more
exaly  

The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury

Expert Review of Gastroenterology and Hepatology, 2018
Hong Fang, Shraddha Thakkar, Zhichao Liu   +2 more
exaly  

Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019

Frontiers in Pharmacology, 2019
Rolf Teschke
exaly  

Models of Drug Induced Liver Injury (DILI) – Current Issues and Future Perspectives

Current Drug Metabolism, 2018
Tomislav Kizivat, Martina Smolic, George Wu   +2 more
exaly  

Exploring Individual Variability in Drug-Induced Liver Injury (DILI) Responses through Metabolomic Analysis

International Journal of Molecular Sciences
Marta Moreno Torres, Teresa Martínez-Sena, Guillermo Quintás   +2 more
exaly  

New approach methodologies (NAMs) for drug-induced liver injury (DILI): Where are we now?

Drug Discovery Today
Minjun Chen, Dongying Li, Weida Tong
exaly  

Roadmap to DILI research in Europe. A proposal from COST action ProEuroDILINet

Pharmacological Research
G P Aithal, R J Andrade, J P Miranda
exaly  

Immunology Highlights of Four Major Idiosyncratic DILI Subtypes Verified by the RUCAM: A New Evidence-Based Classification

Livers
Rolf Teschke
exaly